10x Genomics to Report First Quarter Financial Results on May 5, 2021
April 08 2021 - 4:05PM
10x Genomics (Nasdaq: TXG) today announced it will report financial
results for the first quarter 2021 after market close on Wednesday,
May 5th, 2021. The company’s management will webcast a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time to discuss its results, business
developments and outlook.
Live audio of the webcast will be available on the “Investors”
section of the company website at: www.10xgenomics.com. The webcast
will be archived and available for replay for at least 45 days
after the event.
About 10x Genomics10x Genomics is a life
science technology company building products to interrogate,
understand and master biology to advance human health. The
company’s integrated solutions include instruments, consumables and
software for analyzing biological systems at a resolution and scale
that matches the complexity of biology. 10x Genomics products have
been adopted by researchers around the world, including all of the
top 100 global research institutions, as ranked by Nature in 2019,
and all of the top 20 global pharmaceutical companies, as ranked by
2019 research and development spend, and have been cited in over
2,250 research papers on discoveries ranging from oncology to
immunology, and neuroscience. The company’s patent portfolio
comprises more than 1,000 patents and patent applications.
Disclosure Information10x Genomics uses filings
with the Securities and Exchange Commission, its website
(www.10xgenomics.com), press releases, public conference calls,
public webcasts and its social media accounts as means of
disclosing material non-public information and for complying with
its disclosure obligations under Regulation FD.
ContactsMedia:media@10xgenomics.com
Investors:investors@10xgenomics.com
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Sep 2024 to Oct 2024
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Oct 2023 to Oct 2024